NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.84
-0.43 (-5.91%)
Jun 5, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $78.7 million as of June 5, 2026. Its market cap has increased by 207.85% in one year.
Market Cap
78.70M
Enterprise Value
71.97M
1-Year Change
207.85%
Ranking
Category
Stock Price
$6.84
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $78.70M, an increase of 328.35%. That is a compound annual growth rate of 67.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 78.70M | 62.72% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 82.81M |
| Heron Therapeutics | 82.20M |
| Aardvark Therapeutics | 81.16M |
| Lixte Biotechnology Holdings | 80.80M |
| Annovis Bio | 80.19M |
| eXoZymes | 79.70M |
| MAIA Biotechnology | 79.65M |
| Champions Oncology | 78.74M |